Cancer Research - Europa

Cancer control, Survivorship
and outcomes research
The projects included in this part of the catalogue have a particular importance in controlling cancer
and although they belong to diff erent scientifi c areas, their contribution to the portfolio is important.
The fi rst group of projects belongs to what could be called analysis of funding provision in research,
proposals to enhance quality of the funders and surveillance. The CCRB project aims to improve cancer
control by linking biobanks and cancer registries through integration activities; EUROCAN +PLUS,
a coordination activity of the European research area (ERA), is trying to identify research where
national coordination is lacking and whether there is a possibility to achieve better coordination.
EUSTIR, although a smaller scale project than the ones previously mentioned, has an equally important
objective to propose harmonisation activities in breast cancer research funding bodies in order
to achieve better research results and to be able to control breast cancer research more eff ectively.
Quality of life, pain control and management and psychological impact of cancer patients – in short
palliative medicine and care – incorporates in a complex disease such as cancer, which is often incurable,
a continous input from the start of the disease to the end of life care for the patients, their family
and care givers.
This area of research of growing importance receives special attention among funding and policy makers
in cancer research.
There are two projects representing this area of research: NORMOLIFE which is aiming to synthesise
new compounds alternative to opioids, to fi ght pain and reduce side eff ects; EPCRC is an ambitious
project aiming to identify the genetic variation to opioid responses and cachexia, to improve the
classifi cation of pain, depression and cachexia and most importantly to develop guidelines for the
above symptoms.
Elengo Manoussaki